Sommadossi Jean-Pierre
SEC CIK 1296995 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Pres, CEO, COB, Dir | 573.9K | — | $457.4K | 9 | 2024-01-31 | 2026-01-31 |
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
| 11 | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-03 | 2026-01-31+ | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | M - OptEx | $1.24 | +573.0K | 573.9K | +60,956% | +$710.5K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | F - Tax | $4.24 | -106.1K | 467.8K | -18% | -$449.8K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | A - Grant | — | +99.5K | 389.5K | +34% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | M - OptEx | — | +173.5K | 290.0K | +149% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | F - Tax | $3.06 | -88.6K | 300.9K | -23% | -$271.1K |
| MTI | 2024-09-19 | 2024-09-17+ | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale | $4.04 | -58.0K | 5.87M | -1.0% | -$234.2K |
| TI | 2024-06-07 | 2024-06-05 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale | $4.00 | -1,006 | 5.92M | -0.0% | -$4,024 |
| DT | 2024-02-02 | 2024-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | M - OptEx | — | +173.5K | 173.5K | New | — |
| DT | 2024-02-02 | 2024-02-01 | AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale+OE | $3.85 | -56.9K | 116.6K | -33% | -$219.1K |
Purchase Sale Sale after option exercise All abbreviations